These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9005812)

  • 1. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W; Stoldt M; Schinke H
    J Comput Aided Mol Des; 1996 Jun; 10(3):201-12. PubMed ID: 8808737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct conformational preferences of three cyclic beta-casomorphin-5 analogs determined using NMR spectroscopy and theoretical analysis.
    Carpenter KA; Schiller PW; Schmidt R; Wilkes BC
    Int J Pept Protein Res; 1996 Jul; 48(1):102-11. PubMed ID: 8844269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
    Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M
    Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T; Said-Nejad OE; Schiller PW; Goodman M
    Biopolymers; 1991 Jun; 31(7):877-98. PubMed ID: 1655089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. III. Probable binding conformations of mu-agonists with phenylalanine in position 3.
    Shenderovich MD; Nikiforovich GV; Golbraikh AA
    Int J Pept Protein Res; 1991 Apr; 37(4):241-51. PubMed ID: 1654306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG; Verheyden PM; Tourwe D; Van Binst G; Davis P; Burks TF
    Biopolymers; 1992 Aug; 32(8):957-69. PubMed ID: 1330047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
    Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
    Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.
    Vogel D; Schmidt R; Hartung K; Demuth HU; Chung NN; Schiller PW
    Int J Pept Protein Res; 1996 Dec; 48(6):495-502. PubMed ID: 8985782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic retro-inverso dipeptides with two aromatic side chains. II. Conformational analysis.
    Yamazaki T; Nunami K; Goodman M
    Biopolymers; 1991 Nov; 31(13):1513-28. PubMed ID: 1814501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement.
    Anwer MK; Sherman DB; Spatola AF
    Int J Pept Protein Res; 1990 Oct; 36(4):392-9. PubMed ID: 2079394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM; Ferguson RD; Knapp RJ; Lui GK; Yamamura HI; Hruby VJ
    Int J Pept Protein Res; 1992 May; 39(5):401-14. PubMed ID: 1358847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.
    Brandt W
    J Comput Aided Mol Des; 1998 Nov; 12(6):615-21. PubMed ID: 9879509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
    J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
    Stroup AN; Rockwell AL; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.